![](/img/cover-not-exists.png)
Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window: Joint Outcome Table Analysis of the ECASS 3 Trial
Saver, J. L., Gornbein, J., Grotta, J., Liebeskind, D., Lutsep, H., Schwamm, L., Scott, P., Starkman, S.Volume:
40
Language:
english
Journal:
Stroke
DOI:
10.1161/strokeaha.108.543561
Date:
July, 2009
File:
PDF, 340 KB
english, 2009